Dharmik Jadvani

Researcher

UAMS

Also affiliated: B. J. Medical College & Sassoon Hospital (2023); Medical College of Wisconsin (2023); University of Utah (2023); B.J. Medical College (2023)

Unknown Researcher

1 h-index 8 pubs 10 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Dharmik Jadvani's research focuses on investigating clinical outcomes and treatment strategies for various medical conditions. His work includes studies on the impact of SGLT2 inhibitors in pulmonary hypertension and the effect of GLP-1 receptor agonists on atrial fibrillation in patients with chronic kidney disease. He has also examined the incidence and predictors of atrioventricular block after transcatheter tricuspid valve replacement and the risk reduction for sepsis hospitalization in patients with CKD when using P2Y12 receptor inhibitors. Jadvani has contributed to case reports on infective endocarditis involving the Chiari network and olmesartan-induced enteropathy. His research network includes collaborators from the University of Arkansas for Medical Sciences, such as Nishank Jain and Subhi J. Al’Aref.

Metrics

h-index: 1
Publications: 8
Citations: 10

Selected Publications

GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease (2026)

Cardiovascular Drugs and Therapy DOI OpenAlex
Papillary Fibroelastoma Arising From the Coumadin Ridge: A Rare Extravalvular Cardiac Tumor Diagnosed by Multimodality Imaging (2026)

Cureus DOI OpenAlex
Right Atrial Vegetation on a Chiari Network Presenting With Multifocal Pulmonary Lesions (2026)

Cureus DOI OpenAlex
E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023 (2026)

Journal of the Society for Cardiovascular Angiography & Interventions DOI OpenAlex
Late Sinus of Valsalva Sequestration After Transcatheter Aortic Valve Implantation in Native Aortic Valve (2026)

JACC Case Reports DOI OpenAlex
26-A-18480-ACC INCIDENCE AND PREDICTORS OF HIGH-GRADE ATRIOVENTRICULAR BLOCK AFTER TRANSCATHETER TRICUSPID VALVE REPLACEMENT: A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-16106-ACC SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2I) IN PULMONARY HYPERTENSION (PH): A SYSTEMATIC REVIEW (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-10911-ACC EFFECT OF GLUCAGON-LIKE RECEPTOR PEPTIDE-1 AGONISTS ON ATRIAL FIBRILLATION-RELATED EVENTS AND INCIDENCE IN CHRONIC KIDNEY DISEASE (2026)

Journal of the American College of Cardiology DOI OpenAlex
Infective Endocarditis Involving the Chiari Network (2025)

Methodist DeBakey Cardiovascular Journal 1 citation DOI OpenAlex
Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD (2025)

Kidney360 DOI OpenAlex
E-34 | Procedural modification to risk stratify permanent pacemaker implantation post Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis (2025)

Journal of the Society for Cardiovascular Angiography & Interventions DOI OpenAlex
E-115 | Tetra-Hydro-Cannabinoids and Cardiovascular Outcomes - A Meta-Analytical Evaluation of Arrhythmia and Mortality (2025)

Journal of the Society for Cardiovascular Angiography & Interventions DOI OpenAlex
Authors' Reply: Platelet Count, Platelet Volume and CKD (2024)

Journal of the American Society of Nephrology DOI OpenAlex